Caxton Associates LP Haemonetics Corp Transaction History

Caxton Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $285,730 - $412,700	-6,528 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $323,462 - $486,923	6,528 New	6,528 $346,000
Q2 2020 Aug 14, 2020	SELL	$84.96 - $118.91 $173,913 - $243,408	-2,047 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $152,173 - $249,365	2,047 New	2,047 $204,000
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $289,033 - $341,728	-2,467 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$81.74 - $120.34 $201,652 - $296,878	2,467 New	2,467 $297,000
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $245,688 - $316,067	-2,710 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $243,791 - $310,511	2,710 New	2,710 $311,000

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.